What is PTC Therapeutics's current ratio?

PTC Therapeutics (PTCT) reported current ratio of 2.4× in Q1 2026.

How has PTC Therapeutics's current ratio changed year-over-year?

PTC Therapeutics's current ratio decreased by 37.3% year-over-year, from 3.9× to 2.4×.

What is the long-term trend for PTC Therapeutics's current ratio?

Over 5 years (2020 to 2025), PTC Therapeutics's current ratio has grown at a -12.0% compound annual growth rate (CAGR), from 4.4× to 2.3×.

What does current ratio mean?

Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.

PTC Therapeutics PTCT Current ratio

Current ratio at other companies

BioMarin PharmaceuticalsBMRN

5.8×+0.3×

ALN

Alnylam PharmaceuticalsALNY

3.1×+0.1×

BridgeBio PharmaBBIO

1.5×-3.0×

Arrowhead ResearchARWR

6.2×+1.1×

United TherapeuticsUTHR

4.8×-0.7×

BiogenBIIB

3.1×+1.6×

Other financials

Income statement

See full

Revenue$272.6M-76.8%

Operating income$45.0M-95.4%

Net income-$2.8M-100%

EPS (diluted)-$0.03-100%

Balance sheet

See full

Cash & equivalents$834.0M-43.7%

Total debt$395.1M+0.1%

Total equity-$180.5M+2.9%

Total assets$2.9B+8.0%

Cash flow

See full

Operating cash flow-$59.0M-107%

CapEx$1.2M-30.6%

Free cash flow-$60.2M-107%

Valuation

See full

Market cap$6.55B+40.3%

Enterprise value$6.11B+77.3%

P/E8×—

P/S7.9×+5.3×

Profitability

See full

Gross margin96%—

Operating margin1.6%-38.7pp

Net margin42.3%+27.4pp

FCF margin39.1%+32.8pp

Returns & leverage

See full

Return on equity-216.7%—

Debt / equity372.3×—

Where this comes from

Calculated from PTC Therapeutics’s reported figures.

total current assets/total current liabilities=2.4×

Based on the most recent quarter.

The official record: PTC Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about PTC Therapeutics's current ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is PTC Therapeutics's current ratio?: PTC Therapeutics (PTCT) reported current ratio of 2.4× in Q1 2026.
How has PTC Therapeutics's current ratio changed year-over-year?: PTC Therapeutics's current ratio decreased by 37.3% year-over-year, from 3.9× to 2.4×.
What is the long-term trend for PTC Therapeutics's current ratio?: Over 5 years (2020 to 2025), PTC Therapeutics's current ratio has grown at a -12.0% compound annual growth rate (CAGR), from 4.4× to 2.3×.
What does current ratio mean?: Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.